Hamilton Thorne→Astorg
Acquisition · Cash · announced Jul 22, 2024
Announced
Jul 22, 2024
Closed
Dec 2, 2024
Economics
Cash()
Pre-deal · pre-deal mark: 2024, year precision · Astorg press release — Hamilton Thorne acquisition, 2024
C$10.50/share take-private; ~$282M equity value (Weil/Astorg announcement)
Target
Hamilton Thorne
Fertility · Fertility science
HQ Beverly, MA · Founded 1988
Precision laser devices, advanced imaging systems, consumables and software for assisted reproductive technology (ART) and IVF labs — products used in 115+ countries
- Business Wire — Astorg press release (Dec 2, 2024)
- Mergr M&A summary ($388M total)
- Weil Gotshal advisory announcement ($282M)
Acquirer
Astorg
Fertility
HQ Luxembourg
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Combined with Cook Medical RH to create global ART/IVF leader — precision laser instruments and advanced imaging serving 115+ countries
Evidence ladder
Secondary (press / IR)
Business Wire — Astorg press release (Dec 2, 2024)
Tertiary (trade / analyst)
Weil Gotshal advisory announcement (Jul 24, 2024)
Limitations
- Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
- C$10.50/share take-private; ~$282M equity value (Weil/Astorg announcement)
- Pre-deal valuation sourced from: Astorg press release — Hamilton Thorne acquisition, 2024. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Fertility
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.
| Target | Acquirer | Announced | Value | Why included |
|---|---|---|---|---|
| Eugin Group (North American operations) | KKR (via IVI-RMA) | Nov 1, 2023 | same evidence class | |
| Indira IVF | BPEA EQT | Jul 28, 2023 | same evidence class | |
| Modern Fertility | Ro | May 19, 2021 | value band |
Same-sector adjacency — not valuation peers
These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.
| Target | Acquirer | Announced | Value | Vs this deal |
|---|---|---|---|---|
| IVI-RMA Global | KKR | Mar 1, 2022 |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Hamilton Thorne (Fertility). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.